Company Description

PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expert-based contract research, consulting, medical communications, and technology solutions to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the devel... More >>

Q4 2016 Quarterly Results (Final)More Info >>
 Form 10-K
 Form 8-K
Q4 Financial Results and Trended Information
Q4 2016 Quarterly Results (Preliminary)More Info >>
Earnings Press Release
 Form 8-K
Q4 Financial Results and Trended Information

Recent NewsMore Info >>
PAREXEL Announces Execution of Definitive Agreement to Acquire ExecuPharm
Christian Dreger Joins PAREXEL as Senior Vice President, PAREXEL Access and PAREXEL Consulting
PAREXEL International to Present at Wells Fargo Healthcare Conference

EventsMore Info >>
PAREXEL International Investor Day 2016
Thursday, June 30, 2016 9:00 a.m. ET
Supporting Materials
Download Event Supporting Material PAREXEL’s 2016 Investor Day Presentation